Allopurinol, a drug normally prescribed for gout, is being used to test for
tumours in patients at high risk of developing cancer due to genetic or
environmental factors. Developed by researchers at Johns Hopkins University in
Baltimore, Maryland, the test uses allopurinol to temporarily slow DNA
production in cancer cells, causing some components of DNA—called
pyrimidines—to accumulate in the blood. These can be detected in the
patient’s urine.
More from New ¾«¶«´«Ã½
Explore the latest news, articles and features
Popular articles
Trending New ¾«¶«´«Ã½ articles
1
The world's fastest spider tops 3.5 metres per second
2
Babies are born with the neural foundations for maths
3
Where, when and how to watch the 2026 solar eclipse
4
A type of fibre that stimulates GLP-1 release approved for use in food
5
The best new science-fiction novels published in July 2026
6
The weirdness of neutrinos could completely rewrite particle physics
7
Slowdown of AMOC ocean current may be gradual and reversible
8
US government wants to have a useful quantum computer by 2028
9
We’re not the most successful human species
10
I’m the first person whose life was saved by CRISPR base editing
